• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于黏蛋白触发的锇纳米簇作为具有光热增强过氧化物酶样活性的蛋白冠样纳米酶用于肿瘤特异性治疗。

Mucin-Triggered Osmium Nanoclusters as Protein-Corona-Like Nanozymes with Photothermal-Enhanced Peroxidase-Like Activity for Tumor-Specific Therapy.

机构信息

Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Department of Pharmaceutical Analysis, Fujian Medical University, Fuzhou 350004, China.

Laboratory of Clinical Pharmacy, Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.

出版信息

Nano Lett. 2024 Nov 13;24(45):14337-14345. doi: 10.1021/acs.nanolett.4c04026. Epub 2024 Oct 29.

DOI:10.1021/acs.nanolett.4c04026
Abstract

Nanomaterials with peroxidase-like activity and photothermal conversion efficiency have garnered significant attention for their ability to generate cytotoxic hydroxyl radicals and provide synergistic therapeutic effects. Selecting nanozymes with suitable properties and carriers is crucial for maximizing efficacy. While the mucin family is known for its mucoadhesive, glycosylated structures that enhance drug bioavailability and targeting, its potential in nanozymes remains underexplored. Here, we utilize mucin-2 to facilitate osmium nanoclusters (Os@Mucin), creating protein-corona-like nanozymes. This configuration bestows Os@Mucin with excellent peroxidase-like activity (769 U/mg) and photothermal conversion efficiency (22.83%, 808 nm). Mucin-2 promotes Os uptake by cells, allowing Os@Mucin to exhibit tumor environment-responsive peroxidase-like activity, further enhanced under photothermal conditions for targeted cytotoxicity and synergistic effects. experiments demonstrate that this integration effectively treats triple-negative breast cancer. This study innovatively highlights the potential of the mucin family and underscores the promising role of Os nanozymes in tumor therapy.

摘要

具有过氧化物酶样活性和光热转换效率的纳米材料因其能够产生细胞毒性羟自由基并提供协同治疗效果而受到广泛关注。选择具有合适性质和载体的纳米酶对于最大限度地提高疗效至关重要。尽管粘蛋白家族以其具有粘弹性、糖基化结构而闻名,可提高药物的生物利用度和靶向性,但它们在纳米酶中的应用潜力尚未得到充分探索。在这里,我们利用粘蛋白-2 来促进锇纳米团簇(Os@Mucin)的形成,从而构建出具有蛋白冠状结构的纳米酶。这种结构使 Os@Mucin 具有优异的过氧化物酶样活性(769 U/mg)和光热转换效率(22.83%,808nm)。粘蛋白-2 促进了细胞对 Os 的摄取,使 Os@Mucin 能够表现出肿瘤微环境响应性的过氧化物酶样活性,在光热条件下进一步增强,以实现靶向细胞毒性和协同作用。实验表明,这种整合有效地治疗了三阴性乳腺癌。本研究创新性地强调了粘蛋白家族的潜力,并突出了 Os 纳米酶在肿瘤治疗中的应用前景。

相似文献

1
Mucin-Triggered Osmium Nanoclusters as Protein-Corona-Like Nanozymes with Photothermal-Enhanced Peroxidase-Like Activity for Tumor-Specific Therapy.基于黏蛋白触发的锇纳米簇作为具有光热增强过氧化物酶样活性的蛋白冠样纳米酶用于肿瘤特异性治疗。
Nano Lett. 2024 Nov 13;24(45):14337-14345. doi: 10.1021/acs.nanolett.4c04026. Epub 2024 Oct 29.
2
Ligand-Engineering MoS-Osmium Heterostructure as Highly Active and Specific Peroxidase-Mimic Nanozyme for Interference-Free and Multimode Biosensing.配体工程化钼酸锇异质结构作为用于无干扰多模式生物传感的高活性和特异性过氧化物酶模拟纳米酶
Small. 2025 Jun;21(24):e2409610. doi: 10.1002/smll.202409610. Epub 2025 May 2.
3
Multifunctional nanozymes based on MoS₂ for synergistic catalytic activity and cancer photothermal therapy.基于二硫化钼的多功能纳米酶用于协同催化活性和癌症光热治疗。
Nanomedicine (Lond). 2025 Jul;20(13):1621-1635. doi: 10.1080/17435889.2025.2510891. Epub 2025 Jun 4.
4
Parallel comparative studies on composition-dependent peroxidase-like catalytic activity of ultrasmall ferrite nanoparticles.超小铁氧体纳米颗粒的组成依赖性过氧化物酶样催化活性的平行比较研究。
J Mater Chem B. 2025 Jul 16;13(28):8434-8445. doi: 10.1039/d5tb00626k.
5
Synthesis of a covalently linked bismuthene-graphene heterostructure loaded with mitomycin C for combined radio-thermo-chemotherapy of triple-negative breast cancer.负载丝裂霉素C的共价连接铋烯-石墨烯异质结构的合成用于三阴性乳腺癌的联合放射热化疗
J Mater Chem B. 2025 Jul 2;13(26):7769-7784. doi: 10.1039/d5tb00096c.
6
Innovative approaches for cancer treatment: graphene quantum dots for photodynamic and photothermal therapies.创新的癌症治疗方法:用于光动力和光热治疗的石墨烯量子点。
J Mater Chem B. 2024 May 8;12(18):4307-4334. doi: 10.1039/d4tb00255e.
7
Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer.使用双抗体功能化固体脂质纳米颗粒靶向递送DAPT以增强对三阴性乳腺癌的抗肿瘤活性。
Int J Pharm. 2025 Feb 10;670:125142. doi: 10.1016/j.ijpharm.2024.125142. Epub 2024 Dec 31.
8
Synergistic Strain and Ligand Effects Boosting the Activity of Pt-Based Peroxidase Nanozymes for Femtomolar-Level Colorimetric Immunoassay of Protein Biomarkers.协同应变和配体效应增强基于铂的过氧化物酶纳米酶活性用于蛋白质生物标志物的飞摩尔级比色免疫分析
Anal Chem. 2025 Jul 1;97(25):13453-13464. doi: 10.1021/acs.analchem.5c01825. Epub 2025 Jun 20.
9
Nanozymes with biomimetically designed properties for cancer treatment.具有仿生设计特性的用于癌症治疗的纳米酶。
Nanoscale. 2024 Apr 25;16(16):7786-7824. doi: 10.1039/d4nr00155a.
10
Suppression of the HSP90-HIF1α pathway with SNX2112-encapsulated nano-micelles for effective triple-negative breast cancer photothermal combined photodynamic therapy.用包裹SNX2112的纳米胶束抑制HSP90-HIF1α通路用于有效的三阴性乳腺癌光热联合光动力治疗
J Mater Chem B. 2025 Jul 2;13(26):7753-7768. doi: 10.1039/d5tb00071h.

引用本文的文献

1
Phase-specific and laser-modulated polydopamine-chlorella-curdlan hydrogels: pioneering a melanoma integrative therapy.阶段特异性和激光调制的聚多巴胺-小球藻-κ-卡拉胶水凝胶:开创黑色素瘤综合治疗方法
Theranostics. 2025 Jun 23;15(15):7627-7652. doi: 10.7150/thno.113417. eCollection 2025.
2
PA/MR imaging-guided precision phototherapy and efficacy evaluation of hepatocellular carcinoma utilizing a targeted multifunctional nanoprobe.基于靶向多功能纳米探针的PA/MR成像引导下肝癌精准光疗及疗效评估
Front Immunol. 2025 Jun 11;16:1605048. doi: 10.3389/fimmu.2025.1605048. eCollection 2025.
3
Tumor Microenvironment-Driven Structural Transformation of Vanadium-Based MXenzymes to Amplify Oxidative Stress for Multimodal Tumor Therapy.
肿瘤微环境驱动钒基MX酶的结构转变以放大氧化应激用于多模态肿瘤治疗
Adv Sci (Weinh). 2025 Mar;12(11):e2408998. doi: 10.1002/advs.202408998. Epub 2025 Jan 23.